1. Home
  2. IHRT vs PRQR Comparison

IHRT vs PRQR Comparison

Compare IHRT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

HOLD

Current Price

$4.37

Market Cap

711.8M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.21

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHRT
PRQR
Founded
1974
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
711.8M
250.7M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
IHRT
PRQR
Price
$4.37
$2.21
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$4.50
$8.14
AVG Volume (30 Days)
1.1M
604.4K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,856,033,000.00
$18,859,556.00
Revenue This Year
$1.96
N/A
Revenue Next Year
$5.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.39
N/A
52 Week Low
$0.95
$1.07
52 Week High
$5.44
$3.10

Technical Indicators

Market Signals
Indicator
IHRT
PRQR
Relative Strength Index (RSI) 55.73 49.00
Support Level $4.26 $2.15
Resistance Level $5.44 $2.49
Average True Range (ATR) 0.36 0.18
MACD 0.00 0.01
Stochastic Oscillator 41.26 52.17

Price Performance

Historical Comparison
IHRT
PRQR

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: